{
"id":"mk19_b_en_t01",
"number":1,
"bookId":"en",
"title":{
"__html":"Screening Guidelines for Prediabetes or Type 2 Diabetes Mellitus in Asymptomatic Adults"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"daa97e",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 1. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_en_t01"
}
]
},
"Screening Guidelines for Prediabetes or Type 2 Diabetes Mellitus in Asymptomatic Adults"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"col hd l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cc9fff",
"class":"col hd l",
"children":[
"ADA (2022)",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"70dcba",
"class":"col hd l",
"children":[
"USPSTF (2021)"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"667a37",
"class":"cell txt l",
"children":[
"Screening criteria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d88c2b",
"class":"cell txt l",
"children":[
"Screen overweight adults (BMI ≥25 or ≥23 in Asian Americans) with at least one additional risk factor:"
]
},
" ",
{
"type":"p",
"hlId":"c66d8d",
"class":"cell txt li",
"children":[
"First-degree relative with diabetes"
]
},
" ",
{
"type":"p",
"hlId":"3daa43",
"class":"cell txt li",
"children":[
"High-risk race/ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander)"
]
},
" ",
{
"type":"p",
"hlId":"a5ac95",
"class":"cell txt li",
"children":[
"History of CVD"
]
},
" ",
{
"type":"p",
"hlId":"4d56a5",
"class":"cell txt li",
"children":[
"Physical inactivity"
]
},
" ",
{
"type":"p",
"hlId":"b49d72",
"class":"cell txt li",
"children":[
"Hypertension (≥140/90 mm Hg or on antihypertensive therapy)"
]
},
" ",
{
"type":"p",
"hlId":"21cb45",
"class":"cell txt li",
"children":[
"HDL cholesterol <35 mg/dL (0.90 mmol/L) and/or triglyceride >250 mg/dL (2.82 mmol/L)"
]
},
" ",
{
"type":"p",
"hlId":"e0eff6",
"class":"cell txt li",
"children":[
"Polycystic ovary syndrome"
]
},
" ",
{
"type":"p",
"hlId":"6e2a05",
"class":"cell txt li",
"children":[
"Other conditions associated with insulin resistance (severe obesity, acanthosis nigricans)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c54277",
"class":"cell txt l",
"children":[
"Screen adults aged 35 to 70 years who have overweight or obesity as part of risk assessment for cardiovascular disease."
]
},
" ",
{
"type":"p",
"hlId":"dab5d3",
"class":"cell txt l",
"children":[
"Screening for other modifiable risk factors for CVD"
]
},
" ",
{
"type":"p",
"hlId":"c58b34",
"class":"cell txt li",
"children":[
"Overweight"
]
},
" ",
{
"type":"p",
"hlId":"9f8251",
"class":"cell txt li",
"children":[
"Obesity"
]
},
" ",
{
"type":"p",
"hlId":"4d56a5",
"class":"cell txt li",
"children":[
"Physical inactivity"
]
},
" ",
{
"type":"p",
"hlId":"030502",
"class":"cell txt li",
"children":[
"Abnormal lipid levels"
]
},
" ",
{
"type":"p",
"hlId":"d974e1",
"class":"cell txt li",
"children":[
"High blood pressure"
]
},
" ",
{
"type":"p",
"hlId":"759f43",
"class":"cell txt li",
"children":[
"Smoking"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e9c41d",
"class":"cell txt l",
"children":[
"Additional screening criteria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b7afcd",
"class":"cell txt l",
"children":[
"All adults aged 35 years or older"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26a7c0",
"class":"cell txt l",
"children":[
"Additional screening considerations"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c6f5cc",
"class":"cell txt l",
"children":[
"Consider screening patients taking medications known to increase the risk of diabetes, such as glucocorticoids, thiazide diuretics, HIV medications, and atypical antipsychotics."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bc02bc",
"class":"cell txt l",
"children":[
"Diabetes may occur in younger patients or at a lower BMI. Consider screening earlier if one of the following risk factors is present:"
]
},
" ",
{
"type":"p",
"hlId":"1953ff",
"class":"cell txt li",
"children":[
"Family history of diabetes"
]
},
" ",
{
"type":"p",
"hlId":"35f7b8",
"class":"cell txt li",
"children":[
"History of gestational diabetes"
]
},
" ",
{
"type":"p",
"hlId":"e0eff6",
"class":"cell txt li",
"children":[
"Polycystic ovary syndrome"
]
},
" ",
{
"type":"p",
"hlId":"f4cbff",
"class":"cell txt li",
"children":[
"High-risk race/ethnicity (Black, Hispanic/Latino, Asian American, American Indian/Alaskan Native, Native Hawaiian/Pacific Islander)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"93de31",
"class":"cell txt l",
"children":[
"Screening intervals"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3ea71d",
"class":"cell txt l",
"children":[
"Rescreen every 3 years if results are normal"
]
},
" ",
{
"type":"p",
"hlId":"422028",
"class":"cell txt l",
"children":[
"Monitor patients with a history of prediabetes (hemoglobin A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1c"
]
},
" 5.7%-6.4%, IGT, or IFG) annually"
]
},
" ",
{
"type":"p",
"hlId":"7ca072",
"class":"cell txt l",
"children":[
"Test patients with a history of gestational diabetes at least every 3 years"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"be2a45",
"class":"cell txt l",
"children":[
"Data supporting optimal screening intervals are limited. Rescreening every 3 years may be reasonable."
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"ADA = American Diabetes Association; CVD = cardiovascular disease; IFG = impaired fasting glucose; IGT = impaired glucose tolerance; USPSTF = U.S. Preventive Services Task Force."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"An optional ADA screening tool for diabetes risk can be found at ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.diabetes.org/risk-test",
"target":"_blank"
},
"children":[
"www.diabetes.org/risk-test"
]
},
"."
],
[
"Recommendations from Davidson KW, Barry MJ, Mangione CM, et al; U.S. Preventive Services Task Force. Screening for prediabetes and type 2 diabetes: U.S. Preventive Services Task Force recommendation statement. JAMA. 2021;326:736-743. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/34427594",
"target":"_blank"
},
"children":[
"PMID: 34427594"
]
},
" doi:10.1001/jama.2021.12531; American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2022. Diabetes Care. 2022;45:S17-S38. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/34964875",
"target":"_blank"
},
"children":[
"PMID: 34964875"
]
},
" doi:10.2337/dc22-S002"
]
]
}